Screener
Pfizer PFE EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Pfizer’s 8-K, filed August 4, 2026. Open the filing →
- Filed
- Aug 4, 2026, 7:02 AM EDT
- Accession
- 0000078003-26-000094
FAQ
- What is Pfizer's EPS (diluted)?
- Pfizer (PFE) reported EPS (diluted) of -$0.04 in Q2 2026.
- How has Pfizer's EPS (diluted) changed year-over-year?
- Pfizer's EPS (diluted) decreased by 107.8% year-over-year, from $0.51 to -$0.04.
- What is the long-term trend for Pfizer's EPS (diluted)?
- Over 2 years (2021 to 2024), Pfizer's EPS (diluted) has grown at a -39.4% compound annual growth rate (CAGR), from $3.84 to $1.41.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Pfizer's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude